Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours (Q45768686)

15 December 2017

title

Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours (English)

1 reference

15 December 2017

author

Simon Chu

5

1 reference

15 December 2017

Jolon Matthew Dyer

9

1 reference

15 December 2017

author name string

Adam Rainczuk

1

1 reference

15 December 2017

Jyothsna R Rao

2

1 reference

15 December 2017

Jessica L Gathercole

3

1 reference

15 December 2017

Nicole J Fairweather

4

1 reference

15 December 2017

Rina Masadah

6

1 reference

15 December 2017

Thomas W Jobling

7

1 reference

15 December 2017

Santanu Deb-Choudhury

8

1 reference

15 December 2017

Andrew N Stephens

10

1 reference

15 December 2017

language of work or name

English

0 references

publication date

28 August 2013

1 reference

15 December 2017

International Journal of Cancer

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 December 2017

volume

134

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

530-541

1 reference

15 December 2017

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

cites work

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells

21 January 2018

1 reference

The emerging role of CXC chemokines in epithelial ovarian cancer

21 January 2018

1 reference

CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.

21 January 2018

1 reference

An IP-10 (CXCL10)-derived peptide inhibits angiogenesis

21 January 2018

1 reference

The dipeptidyl peptidase IV family in cancer and cell biology.

21 January 2018

1 reference

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

21 January 2018

1 reference

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.

21 January 2018

1 reference

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes

21 January 2018

1 reference

Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

Post-translational modifications and protein-specific isoforms in endometriosis revealed by 2D DIGE.

21 January 2018

1 reference

Proteomic approach identifies alterations in cytoskeletal remodelling proteins during decidualization of human endometrial stromal cells.

21 January 2018

1 reference

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation

21 January 2018

1 reference

Expression of IP-10 related to angiogenesis in uterine cervical cancers

21 January 2018

1 reference

Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.

21 January 2018

1 reference

Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis

21 January 2018

1 reference

Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding

21 January 2018

1 reference

Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity.

21 January 2018

1 reference

Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation

21 January 2018

1 reference

Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8

21 January 2018

1 reference

Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV.

21 January 2018

1 reference

The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells

21 January 2018

1 reference

Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects

21 January 2018

1 reference

Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines.

21 January 2018

1 reference

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

21 January 2018

1 reference

Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats.

21 January 2018

1 reference

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

21 January 2018

1 reference

Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28393

1 reference

15 December 2017

1 reference

15 December 2017